LakeShore Biopharma Co., Ltd

NasdaqCM:LSB Stock Report

Market Cap: US$56.5m

LakeShore Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:LSB Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
08 Feb 24BuyUS$0Fung Ching WongIndividual309,033.2US$5.23
07 Feb 24BuyUS$40,003,773Fung Ching WongIndividual9,526,976.2US$4.20

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LSB?
Owner TypeNumber of SharesOwnership Percentage
Private Companies385,3482.02%
Institutions786,0364.12%
General Public2,812,50614.7%
Individual Insiders15,096,86179.1%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 105%.

Top Shareholders

Top 20 shareholders own 85.26% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
51.6%
Fung Ching Wong
9,836,009US$29.1m0%no data
25.7%
Yi Zhang
4,908,919US$14.5m0%no data
2.43%
Oceanpine Capital Limited
462,760US$1.4m0%no data
2.02%
Summit Healthcare Acquisition Sponsor LLC
385,348US$1.1m0%no data
1.64%
Hui Shao
313,638US$928.4k0%no data
0.61%
Impresa Management LLC
116,507US$344.9k0%0.18%
0.39%
Hillhouse Investment Management, Ltd.
75,179US$222.5k0%no data
0.32%
Fidelity International Ltd
61,547US$182.2k-16.1%no data
0.16%
Superstring Capital Management LP
30,792US$91.1k0%0.09%
0.13%
Barclays PLC Private Banking & Investment Banking Investment
24,757US$73.3k0%no data
0.051%
Chunyuan Wu
9,750US$28.9k0%no data
0.049%
BMO Asset Management Corp.
9,380US$27.8k-68%no data
0.045%
Ajit S. Shetty
8,625US$25.5k0%no data
0.043%
Yi Chang
8,211US$24.3k0%no data
0.038%
Viren Mehta
7,250US$21.5k0%no data
0.026%
UBS Asset Management AG
4,941US$14.6k0%no data
0.0092%
Amita Rodman
1,750US$5.2k0%no data
0.0072%
Christine Clerinx
1,375US$4.1k0%no data
0.007%
Nan Zhang
1,334US$3.9k0%no data
0.00091%
Manulife Investment Management (North America) Limited
173US$514.00%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 11:37
End of Day Share Price 2024/12/20 00:00
Earnings2024/03/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

LakeShore Biopharma Co., Ltd is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hunter DiamondDiamond Equity Research LLC
Gregory AurandNOBLE Capital Markets, Inc.